NCT06607445View on ClinicalTrials.gov

"Evaluation of the Implementation of the Pharmacogenetics and Personalized Medicine Program MedeA in the Extremadura Health Service."

RecruitingOBSERVATIONAL

Enrollment

6,445

Participants

Timeline

Start Date

May 26, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Adverse Drug Event

Trial Locations (1)

06080

RECRUITING

Complejo Hospitalario Universitario de Badajoz, Badajoz

All Listed Sponsors

lead

Complejo Hospitalario Universitario de Badajoz

OTHER